logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
A

Anti-Cancer Drugs

IF2.2
Papers50
Citations4204
Journal Papers 50
Publication Date
delete
Initial stage analysis of tislelizumab in combination with chemotherapy for patients with advanced HIV-positive non-small-cell lung cancer: a comparative clinical trial
deleteAnti-Cancer Drugs
IF2.2
delete2026-04-01
delete1
PREAI
deleteQuan, Yaping; Li, Hao; Liang, Zhengjie; Shen, Jie; Hu, Yong
deleteShare
deleteSave
EP4 influences bortezomib resistance in multiple myeloma by modulating endoplasmic reticulum stress via the phosphatidylinositol 3-kinase/protein kinase B pathway
deleteAnti-Cancer Drugs
IF2.2
delete2026-04-01
delete0
PREAI
deleteShi, Tengfei; Chen, Yao; Liu, Zhiqiang; Liu, Aichun
deleteShare
deleteSave
Locoregional and symptomatic response to neoadjuvant dual HER2 blockade with chemotherapy in HER2-positive breast cancer: a pilot study
deleteAnti-Cancer Drugs
IF2.2
delete2026-04-01
delete0
PREAI
deleteChowdhary, Gurjeet Singh; Nayyar, Ankush; Vasudevan, Sridharan; Kaur, Kamalpreet
deleteShare
deleteSave
Comparative efficacy and safety of S-1 plus oxaliplatin with sintilimab vs. paclitaxel-S-1-oxaliplatin and docetaxel-oxaliplatin-5-fluorouracil as first-line therapy for advanced gastric cancer
deleteAnti-Cancer Drugs
IF2.2
delete2026-04-01
delete0
PREAI
deleteWang, Yicong; Ma, Bingyang; Zhang, Chenguang; Wang, Yuwen; Pan, Ting; Zhao, Chunlong; Cai, Baojia; Yu, Pengjie; Guo, Bin; Ma, Jinfu
deleteShare
deleteSave
Multimodal treatment with thiotepa, bevacizumab, teniposide, and tunlametinib in a patient with neurofibromatosis type 1-associated oligodendroglioma: a rare case report
deleteAnti-Cancer Drugs
IF2.2
delete2026-04-01
delete0
PREAI
deleteZhou, Shizhen; Chen, Yanfei; Gao, Guoliang; Pan, Xueqiang; Sun, Peng; Tao, Rongjie
deleteShare
deleteSave
Histone lactylation promoted colorectal cancer progression by enhancing tumor necrosis factor transcription and served as a diagnostic biomarker
deleteAnti-Cancer Drugs
IF2.2
delete2026-03-01
delete1
PREAI
deleteLi, Shiyang; Shi, Xiufang; Zhou, Xiaoyue
deleteShare
deleteSave
Clinical importance of the interactions between the TGF-β1/SMAD and NF-κB pathways in colorectal cancer and the study of the synergistic regulatory mechanism of the STAT3-mediated pathway
deleteAnti-Cancer Drugs
IF2.2
delete2026-03-01
delete0
PREAI
deleteChao, Huang; Liu, Haosheng; Shen, Weizeng
deleteShare
deleteSave
The evolving landscape of KRAS-targeted therapy: mechanisms of resistance and emerging strategies
deleteAnti-Cancer Drugs
IF2.2
delete2026-03-01
delete0
PREAI
deletePilco-Janeta, Daniel F.; De la Cruz-Puebla, Myriam
deleteShare
deleteSave
Apatinib triggers ferroptosis in gastric cancer via HDAC1/HIF1α/CA9 signaling axis
deleteAnti-Cancer Drugs
IF2.2
delete2026-03-01
delete0
PREAI
deleteMeng, Lijuan; Cao, Lei; Lu, Yueyao; Yang, Lixin; Zhu, Weiyou
deleteShare
deleteSave
Activation of the caspase-1/gasdermin D pathway via α-linolenic acid-mediated GPR120 signaling induces pyroptosis and suppresses ovarian cancer tumor growth
deleteAnti-Cancer Drugs
IF2.2
delete2026-03-01
delete1
PREAI
deleteSun, Shijie; Qian, Li
deleteShare
deleteSave
Identification of uridine phosphatase 1 as a potential therapeutic target in gastric cancer by integrated bioinformatics analysis and experimental validation
deleteAnti-Cancer Drugs
IF2.2
delete2026-03-01
delete0
PREAI
deleteWang, Yongfeng; Feng, Yichen; Zhu, Chengzhang; Guan, Ling; Wang, Shengfeng; Zou, Anqi; Yu, Miao; Yuan, Yuan; Cai, Hui
deleteShare
deleteSave
Collagen I is the effective therapeutic target for treating desmoid tumors
deleteAnti-Cancer Drugs
IF2.2
delete2026-03-01
delete0
PREAI
deleteLee, Yehyeong; Kim, Yonghyo; Lee, Chankyoung; Kim, Tae Il; Cho, Yong-Hee
deleteShare
deleteSave
Successful treatment with erlotinib plus ramucirumab in a patient with non-small-cell lung cancer harboring EGFR exon 20 insertion mutation
deleteAnti-Cancer Drugs
IF2.2
delete2026-02-01
delete1
PREAI
deleteNakashima, Koki; Yamaoka, Koji; Umeda, Yukihiro; Waseda, Yuko
deleteShare
deleteSave
Anti-CD19 antibody tafasitamab therapy for relapsed or refractory diffuse large B-cell lymphoma: a case series
deleteAnti-Cancer Drugs
IF2.2
delete2026-02-01
delete1
PREAI
deleteYou, Jianhua; Chen, Wenting; Yan, Zixun; Tian, Dengmei; Yi, Hongmei; Feng, Yuan; Zhang, Mengping; Xing, Tingting; Wang, Zhi; Zhao, Weili; Xu, Pengpeng
deleteShare
deleteSave
A genome-wide screen identified ARHGAP35 as a regulator of regorafenib resistance in liver cancer
deleteAnti-Cancer Drugs
IF2.2
delete2026-02-01
delete1
PREAI
deleteChen, Kun; Zhang, Miaomiao; Liu, Yuexin; Dong, Zhengnan; Liang, Yaoji; Zeng, Jinzhang; Liu, Jie
deleteShare
deleteSave
A novel anticancer natural product SP09 selectively targets KRAS-mutant NSCLC through LKB1/AMPK/mTOR modulation: implications for novel therapeutic development
deleteAnti-Cancer Drugs
IF2.2
delete2026-02-01
delete0
PREAI
deleteYue, Peng; Hon, Chitin; Zhao, Xiaoping; Ali, Fayaz; Sun, Jiayi; Kou, Jiyou
deleteShare
deleteSave
Adiponectin Receptor 1-vascular endothelial growth factor axis mediates resistance to epidermal growth factor receptor-targeted therapy in nasopharyngeal carcinoma
deleteAnti-Cancer Drugs
IF2.2
delete2026-02-01
delete0
PREAI
deleteCheng, Zilu; Peng, Xiaohong; Wu, Shuting; Li, Wanxia; Liu, Xiong; Zhang, Guohua
deleteShare
deleteSave
Serum heat shock protein family A member 9 protein as a biomarker for bortezomib resistance and poor prognosis in patients with multiple myeloma
deleteAnti-Cancer Drugs
IF2.2
delete2026-02-01
delete0
PREAI
deleteChen, Lin; Gao, Shuang; Lin, Li; Liu, Su; Ma, Jing; Zhang, Zhiying; Li, Qian
deleteShare
deleteSave
Distribution of side effects of anti-EGFR treatments in patients with metastatic colorectal cancer and evaluation of their relationship with survival
deleteAnti-Cancer Drugs
IF2.2
delete2026-02-01
delete1
PREAI
deleteErciyestepe, Mert; Aydin, Okan; Sonusen, Sermin Dinc; Ozturk, Ahmet Emin; Celik, Emir; Atci, Muhammed Mustafa; Erturk, Kayhan
deleteShare
deleteSave
Low relative dose intensity adjuvant chemotherapy in elderly patients with breast cancer: predictors and impact on survival
deleteAnti-Cancer Drugs
IF2.2
delete2026-02-01
delete0
PREAI
deleteRamos-Esquivel, Allan; Romero-Orocu, David; Mora-Hidalgo, Raquel
deleteShare
deleteSave